期刊
HEALTH SERVICES RESEARCH
卷 46, 期 6, 页码 1963-1985出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1475-6773.2011.01286.x
关键词
Cost sharing; medication adherence; diabetes; hypertension; veterans
资金
- Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [IIR 03-200]
- Department of Veteran Affairs Office of Academic Affiliations
- AHRQ [K12 HS 019479]
Objectives. To compare changes in medication adherence between patients with high- or low-comorbidity burden after a copayment increase. Methods. We conducted a retrospective observational study at four Veterans Affairs (VA) medical centers by comparing veterans with hypertension or diabetes required to pay copayments with propensity score-matched veterans exempt from copayments. Disease cohorts were stratified by Diagnostic Cost Group risk score: low-(<1) and high-comorbidity (>1) burden. Medication adherence from February 2001 to December 2003, constructed from VA pharmacy claims data based on the ReComp algorithm, were assessed using generalized estimating equations. Results. Veterans with lower comorbidity were more responsive to a U.S.$5 copayment increase than higher comorbidity veterans. In the lower comorbidity groups, veterans with diabetes had a greater reduction in adherence than veterans with hypertension. Adherence trends were similar for copayment-exempt and nonexempt veterans with higher comorbidity. Conclusion. Medication copayment increases are associated with different impacts for low- and high-risk patients. High-risk patients incur greater out-of-pocket costs from continued adherence, while low- risk patients put themselves at increased risk for adverse health events due to greater nonadherence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据